SenesTech (NASDAQ:SNES) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNESFree Report) in a research report sent to investors on Thursday morning. The firm issued a sell rating on the stock.

SenesTech Stock Down 0.9 %

NASDAQ:SNES opened at $2.79 on Thursday. The business’s fifty day moving average price is $2.93 and its 200 day moving average price is $5.09. The company has a debt-to-equity ratio of 0.05, a current ratio of 4.68 and a quick ratio of 3.49. SenesTech has a 1-year low of $1.90 and a 1-year high of $45.60.

SenesTech (NASDAQ:SNESGet Free Report) last issued its earnings results on Thursday, August 8th. The company reported ($3.08) earnings per share for the quarter, beating analysts’ consensus estimates of ($3.20) by $0.12. SenesTech had a negative return on equity of 168.64% and a negative net margin of 464.09%. The company had revenue of $0.46 million for the quarter, compared to the consensus estimate of $0.49 million. During the same quarter in the prior year, the company earned ($84.03) EPS. As a group, equities research analysts expect that SenesTech will post -11 EPS for the current fiscal year.

About SenesTech

(Get Free Report)

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

See Also

Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.